Modest Coffee Intake Linked to Lower Recurrent AFib After Cardioversion
A randomized clinical trial suggests that consuming modest amounts of caffeinated coffee after electrical cardioversion may be linked to a lower risk of recurrent atrial fibrillation (AFib).
Background on Atrial Fibrillation and Coffee
Atrial fibrillation is a prevalent heart rhythm disorder. Historically, caffeinated coffee has been considered a potential trigger for AFib episodes. However, recent randomized controlled trials and observational studies have not consistently shown increased AFib episodes due to coffee intake.
Study Design
Researchers from the University of California, San Francisco, conducted a 6-month randomized clinical trial involving 200 current or prior coffee drinkers who had undergone electrical cardioversion for persistent AFib or atrial flutter. Participants were divided into two groups:
- Intervention Group: Instructed to drink at least one cup of caffeinated coffee daily.
- Control Group: Encouraged to abstain from caffeinated and decaffeinated coffee, as well as other caffeine-containing products.
Participants were followed for six months to evaluate the risk of clinically detected recurrence of AFib or atrial flutter.
Key Findings
- AFib or atrial flutter recurrence was detected in 47% of participants in the intervention group, compared to 64% in the control group.
- The time to recurrence was longer in the intervention group, corresponding to a 39% lower hazard of recurrence for participants assigned to consume caffeinated coffee.
- The number of participants requiring hospitalization for AFib or atrial flutter was numerically higher in the control group (15 events) than in the intervention group (10 events).
AFib or atrial flutter recurrence was detected in 47% of participants in the intervention group, compared to 64% in the control group.
Potential Mechanisms and Caveats
The study proposes that caffeine's ability to block adenosine receptors, along with anti-inflammatory and blood pressure-lowering properties of coffee, may contribute to the observed effects. Coffee intake has also been linked to increased physical activity.
The authors caution that these findings are specific to modest caffeine intake in a post-cardioversion setting and do not apply to high-dose caffeine or patients with paroxysmal AFib. The study does not establish coffee consumption as a proven preventive strategy, and further research is recommended.
The authors caution that these findings are specific to modest caffeine intake in a post-cardioversion setting and do not apply to high-dose caffeine or patients with paroxysmal AFib.
Study Limitations
The study was not blinded, meaning both participants and clinicians were aware of the caffeine exposure, which could introduce bias. Adherence to the abstinence protocol in the control group was incomplete, potentially underestimating the true difference between groups. Recurrence was identified through routine clinical care rather than continuous rhythm monitoring.